Immunology and Microbiology
Aspergillus
100%
Candida Albicans
96%
Aspergillus fumigatus
54%
Candida
49%
Phagocytosis
40%
Neutrophil Granulocyte
37%
Intracellular Killing
27%
Enzyme-Linked Immunosorbent Assay
26%
Trichophyton Mentagrophytes
25%
Infectious Agent
24%
Mouse
22%
Arthroconidia
19%
Human Immunodeficiency Virus
18%
Polymerase Chain Reaction
18%
Minimum Inhibitory Concentration
18%
Allergic Bronchopulmonary Aspergillosis
17%
Immunoglobulin G Antibody
15%
Biofilm
14%
ELISA
14%
Monospecific Antibody
14%
Conidium
14%
Neutrophil
13%
Autoimmune Polyendocrine Syndrome Type 1
13%
Dermatophyte
13%
Phagocyte
13%
Prevalence
12%
Serology
11%
Yeast Cell
11%
Real-Time Polymerase Chain Reaction
10%
Malassezia Furfur
10%
Mortality Rate
8%
Awareness
8%
Mould
8%
Immunocompromised Patient
8%
Filobasidiella
7%
Transplant Procedure
7%
Pneumocystis
7%
Precipitin Test
7%
Cryptococcus neoformans
7%
Lateral Flow Assay
7%
Sputum
7%
Immune Response
6%
C-Reactive Protein
6%
Sinusitis
6%
Fungus Antigen
6%
Immunodeficiency
6%
Enzyme Immunoassay
6%
Interleukin-6
6%
Periodontitis
6%
Candida Auris
6%
Pharmacology, Toxicology and Pharmaceutical Science
Aspergillus
55%
Infection
37%
Antifungal Agent
34%
Disease
32%
Lung Aspergillosis
30%
Pyrrole
29%
Candida Albicans
25%
Aspergillosis
21%
Invasive Aspergillosis
21%
Aspergillus fumigatus
20%
Candida
19%
Systemic Mycosis
17%
Fluconazole
16%
Itraconazole
16%
Candidiasis
15%
Ketoconazole
15%
Galactomannan
15%
Mycosis
14%
Posaconazole
14%
Enzyme-Linked Immunosorbent Assay
13%
Amphotericin B
12%
Isavuconazole
12%
Therapeutic Drug Monitoring
11%
Voriconazole
10%
Resistance to Antifungal Agent
10%
Mould
9%
Pharmacokinetics
9%
Candidemia
9%
Prevalence
9%
Terbinafine
8%
Nose Polyp
7%
Infectious Agent
7%
Sinusitis
7%
Allergic Bronchopulmonary Aspergillosis
7%
Trichophyton Mentagrophytes
7%
Antifungal Therapy
7%
Candida Auris
6%
Hematologic Malignancy
6%
Enzyme Immunoassay
6%
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy
6%
Antiinfective Agent
6%
Mannan
6%
Dermatophyte
6%
Anidulafungin
5%
Fungus Antigen
5%
Biological Marker
5%
Dermatophytosis
5%
Mouse
5%
Epileptic Absence
5%
Medicine and Dentistry
Infection
46%
Systemic Mycosis
45%
Aspergillus
43%
Diseases
43%
Antifungal Agent
36%
Mycosis
32%
Chronic Pulmonary Aspergillosis
29%
Invasive Aspergillosis
22%
Diagnosis
20%
Medical Mycology
19%
Candidiasis
17%
Pathogen
17%
Antifungal Therapy
14%
Candidemia
13%
Voriconazole
12%
Amphotericin B
12%
Human Immunodeficiency Virus
11%
Allergic Bronchopulmonary Aspergillosis
10%
Hematologic Malignancy
10%
Extracorporeal Membrane Oxygenation
10%
Immunocompromised Patient
9%
Diagnostic Procedure
9%
Glucan
9%
Fluconazole
8%
Galactomannan
7%
Aspergillosis
7%
Posaconazole
7%
Lung Aspergillosis
7%
Mucormycosis
7%
Wassermann Test
7%
Systemic Candidiasis
7%
Itraconazole
7%
Therapeutic Drug Monitoring
7%
Polymerase Chain Reaction
6%
Cooperation
6%
Sputum
6%
Cohort Effect
6%
Early Diagnosis
6%
Biological Marker
6%
Pyrrole
5%
In Vitro
5%
Lung Tuberculosis
5%
Pediatrics Patient
5%
Phaeohyphomycosis
5%
Polymerase Chain Reaction
5%
Zygomycosis
5%